Salpeter, Shelley R.

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E. (2010) · Cochrane Database of Systematic Reviews

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 893

Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women

Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism

Menopause: Health Impacts and TreatmentsHormonal and reproductive studies

Cited by 640

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function–a meta-analysis

Kielstein, J. T., Salpeter, S. R., Bode-Boeger, S. M., Cooke, J. P., & Fliser, D. (2006) · Nephrology Dialysis Transplantation

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 363

Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis

Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2003) · Archives of Internal Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 312

Meta-analysis: metformin treatment in persons at risk for diabetes mellitus

Salpeter, S. R., Buckley, N. S., Kahn, J. A., & Salpeter, E. E. (2008) · The American Journal of Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 248

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2006) · The Cochrane Database of Systematic Reviews (Complete Reviews)

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 163